Jamal Jilani

Prof. Jamal Jilani


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
JJJamal Jilani
Jamal Jilani
MSMaha Shomaf
Maha Shomaf
KAKarem Alzoubi
Karem Alzoubi
Peer reviewed article authored by (Jilani JA, Shomaf M, Alzoubi KH). Read article or submit your manuscript for publishing.

8 May 2022 in Molecules
Verified
Journal Article
Open access
PDF file
RArami ayoub
rami ayoub
JJJamal Jilani
Jamal Jilani
QJQais Jarrar
Qais Jarrar
RARaad Alani
Raad Alani
ACArdianto Chrismawan
Ardianto Chrismawan
SMSaid Moshawih
Said Moshawih
2-(4-Chlorophenyl)-5-benzoxazoleacetic acid (CBA) and its ester, methyl-2-(4-chloro-phenyl)-5-benzoxazoleacetate (MCBA), were synthesized, and their structures were confirmed by 1HNMR, IR, and mass spectrophotometry. The anti-psoriatic activities of CBA and MCBA were tested using an imiquimod (IMQ)-induced psoriatic mouse model, in which mice were treated both topically (1% w/w) and orally (125 mg/kg) for 14 days. The erythema intensity, thickness, and desquamation of psoriasis were scored by calculating the psoriasis area severity index (PASI). The study also included the determination of histopathological alterations in the skin tissues of treated mice. Topical and oral administration of CBA and MCBA led to a reduction in erythema intensity, thickness, and desquamation, which was demonstrated by a significant decrease in the PASI value. In addition, skin tissues of mice treated with CBA and MCBA showed less evidence of psoriatic alterations, such as hyperkeratosis, parakeratosis, scale crust, edema, psoriasiform, and hyperplasia. After administration of either topical or oral dosing, the anti-psoriatic effects were found to be stronger in MCBA-treated than in CBA-treated mice. These effects were comparable to those produced by Clobetasol propionate, the reference drug. This drug discovery could be translated into a potential new drug for future clinical use in psoriasis treatment.

1 January 2007 in Chemical Papers
Verified
Journal Article
Closed access
PDF file
JJJamal Jilani
Jamal Jilani